NTIP's Q3 Net Loss Widens Amidst Zero Revenue, Cash Reserves Dwindle

Ticker: NTIP · Form: 10-Q · Filed: Nov 6, 2025 · CIK: 1065078

Network-1 Technologies, Inc. 10-Q Filing Summary
FieldDetail
CompanyNetwork-1 Technologies, Inc. (NTIP)
Form Type10-Q
Filed DateNov 6, 2025
Risk Levelhigh
Pages15
Reading Time18 min
Key Dollar Amounts$0.01
Sentimentbearish

Sentiment: bearish

Topics: Intellectual Property, Patent Licensing, Net Loss, Cash Burn, Litigation Risk, Small Cap, Biotechnology Investment

TL;DR

**NTIP is burning cash with no revenue, making its patent portfolio a risky bet for investors.**

AI Summary

NETWORK-1 TECHNOLOGIES, INC. (NTIP) reported a net loss of $560,000 for the three months ended September 30, 2025, a significant increase from the $316,000 net loss in the prior-year quarter. For the nine months ended September 30, 2025, the net loss was $1,386,000, an improvement from the $1,894,000 net loss in the same period of 2024. Revenue for both the three-month periods was $0, while the nine-month revenue increased to $150,000 in 2025 from $100,000 in 2024, primarily from litigation settlements. Operating expenses decreased to $800,000 for the three months ended September 30, 2025, from $896,000 in 2024, and to $2,315,000 for the nine months from $2,538,000. Cash and cash equivalents declined substantially to $7,708,000 as of September 30, 2025, from $13,145,000 at December 31, 2024, largely due to $2,296,000 in cash dividends paid and $287,000 in common stock repurchases. The company also acquired $415,000 in new patents during the nine-month period.

Why It Matters

NTIP's continued reliance on unpredictable litigation settlements for revenue, coupled with increasing net losses and declining cash reserves, signals significant challenges for investors. The company's strategy of acquiring new patents, such as the $415,000 spent in the last nine months, is a long-term bet that has yet to consistently translate into revenue, putting pressure on its ability to sustain operations and shareholder returns, including its $0.05 quarterly dividend. This performance contrasts sharply with more stable, revenue-generating intellectual property firms, raising questions about NTIP's competitive viability and long-term growth prospects in the IP licensing market.

Risk Assessment

Risk Level: high — The company reported zero revenue for the three months ended September 30, 2025, and a net loss of $560,000 for the same period. Cash and cash equivalents decreased by $5,437,000 during the nine months ended September 30, 2025, falling to $7,708,000 from $13,145,000 at the start of the year, indicating significant cash burn without a stable revenue stream.

Analyst Insight

Investors should exercise extreme caution and consider divesting NTIP shares given the lack of consistent revenue, widening net losses, and significant cash burn. The company's reliance on unpredictable litigation settlements and its declining cash position suggest a high-risk profile with limited near-term upside.

Financial Highlights

debt To Equity
N/A
revenue
$150,000
operating Margin
N/A
total Assets
N/A
total Debt
N/A
net Income
-$1,386,000
eps
N/A
gross Margin
N/A
cash Position
$7,708,000
revenue Growth
+50.0%

Revenue Breakdown

SegmentRevenueGrowth
Litigation Settlements$150,000+50.0%

Key Numbers

  • $7.7M — Cash and Cash Equivalents (Decreased from $13.1M at Dec 31, 2024, a 41% decline)
  • $0 — Revenue (For the three months ended September 30, 2025, indicating no core business income)
  • $560K — Net Loss (Q3 2025) (Increased from $316K in Q3 2024, showing worsening profitability)
  • $1.39M — Net Loss (YTD 2025) (Improved from $1.89M in YTD 2024, but still a significant loss)
  • $415K — Patent Acquisitions (Investment in new patents during the nine months ended September 30, 2025)
  • $2.3M — Cash Dividends Paid (For the nine months ended September 30, 2025, contributing to cash decline)
  • 22.8M — Common Shares Outstanding (As of November 3, 2025, slightly reduced from 22.96M at Dec 31, 2024)
  • $40.5M — Total Stockholders' Equity (Decreased from $44.3M at Dec 31, 2024, a 8.6% decline)

Key Players & Entities

  • NETWORK-1 TECHNOLOGIES, INC. (company) — Registrant as Specified in Its Charter
  • NYSE American (regulator) — Exchange where Common Stock is registered
  • ILiAD Biotechnologies, LLC (company) — Equity method investee
  • $7,708,000 (dollar_amount) — Cash and cash equivalents as of September 30, 2025
  • $13,145,000 (dollar_amount) — Cash and cash equivalents as of December 31, 2024
  • $560,000 (dollar_amount) — Net loss for the three months ended September 30, 2025
  • $1,386,000 (dollar_amount) — Net loss for the nine months ended September 30, 2025
  • $150,000 (dollar_amount) — Revenue for the nine months ended September 30, 2025
  • $415,000 (dollar_amount) — Acquisition of patents during the nine months ended September 30, 2025
  • $0.05 (dollar_amount) — Cash dividends declared per share for the three months ended September 30, 2025

FAQ

What was NETWORK-1 TECHNOLOGIES, INC.'s revenue for the quarter ended September 30, 2025?

NETWORK-1 TECHNOLOGIES, INC. reported $0 in revenue for the three months ended September 30, 2025, indicating no income from its intellectual property licensing activities during that period.

How did NETWORK-1 TECHNOLOGIES, INC.'s net loss change in Q3 2025 compared to the previous year?

NETWORK-1 TECHNOLOGIES, INC.'s net loss for the three months ended September 30, 2025, was $560,000, which is a significant increase from the $316,000 net loss reported for the same period in 2024.

What is the current cash position of NETWORK-1 TECHNOLOGIES, INC. as of September 30, 2025?

As of September 30, 2025, NETWORK-1 TECHNOLOGIES, INC. had $7,708,000 in cash and cash equivalents, a decrease from $13,145,000 at December 31, 2024.

What is NETWORK-1 TECHNOLOGIES, INC.'s primary business strategy?

NETWORK-1 TECHNOLOGIES, INC.'s primary business strategy involves the development, licensing, and protection of its intellectual property assets, including pursuing licensing opportunities for its patent portfolios and acquiring additional high-quality patents.

What are the key risks highlighted in NETWORK-1 TECHNOLOGIES, INC.'s 10-Q filing?

Key risks include uncertain revenue from licensing intellectual property, uncertainty of litigation outcomes, ability to achieve future revenue from patent portfolios, and the risk of being determined a personal holding company, potentially requiring special cash dividends.

How much did NETWORK-1 TECHNOLOGIES, INC. invest in new patents during the nine months ended September 30, 2025?

NETWORK-1 TECHNOLOGIES, INC. invested $415,000 in the acquisition of new patents during the nine months ended September 30, 2025.

Did NETWORK-1 TECHNOLOGIES, INC. pay dividends in the last quarter?

Yes, NETWORK-1 TECHNOLOGIES, INC. declared cash dividends of $0.05 per share for the three months ended September 30, 2025, and $0.10 per share for the nine months ended September 30, 2025.

What was the total operating expense for NETWORK-1 TECHNOLOGIES, INC. for the nine months ended September 30, 2025?

For the nine months ended September 30, 2025, NETWORK-1 TECHNOLOGIES, INC.'s total operating expenses were $2,315,000, a decrease from $2,538,000 in the same period of 2024.

What is the significance of NETWORK-1 TECHNOLOGIES, INC.'s equity investment in ILiAD Biotechnologies, LLC?

NETWORK-1 TECHNOLOGIES, INC. has made equity investments totaling $7,000,000 in ILiAD Biotechnologies, LLC, a clinical-stage biotechnology company, which is accounted for under the equity method and contributes to the company's share of net losses.

How does NETWORK-1 TECHNOLOGIES, INC. recognize revenue from its intellectual property?

NETWORK-1 TECHNOLOGIES, INC. recognizes revenue when it completes the licensing of its intellectual property, obtains a final judgment awarding damages after appeals, or enters into a litigation settlement agreement involving its patents.

Risk Factors

  • Dependence on Patent Licensing and Litigation [high — operational]: The company's revenue is heavily reliant on licensing its patent portfolios and the success of litigation settlements. With $0 revenue in Q3 2025 and a total of $150,000 for the nine months primarily from settlements, any disruption in these activities poses a significant risk to financial performance.
  • Declining Cash Reserves [high — financial]: Cash and cash equivalents decreased by 41% from $13.1 million at December 31, 2024, to $7.7 million as of September 30, 2025. This substantial decline, driven by $2.3 million in cash dividends and $287,000 in stock repurchases, reduces the company's financial flexibility.
  • Patent Expirations [medium — operational]: Out of 115 U.S. patents, 54 have expired. This reduces the pool of revenue-generating assets and necessitates continuous efforts in acquiring and developing new intellectual property to sustain operations.
  • Increasing Net Loss [medium — financial]: The net loss for the three months ended September 30, 2025, increased to $560,000 from $316,000 in the prior-year quarter, indicating worsening profitability in the short term, despite a year-to-date improvement.
  • Equity Investment in Biotechnology [medium — financial]: The company has made a $7,000,000 equity investment in ILiAD Biotechnologies, LLC. The performance and valuation of this investment carry financial risk, as it represents a significant portion of the company's assets.

Industry Context

Network-1 Technologies operates in the intellectual property sector, focusing on developing, licensing, and protecting its patent assets. The company's strategy involves pursuing licensing opportunities for its diverse patent portfolios, including M2M/IoT, HFT, and smart home technologies, while also exploring acquisitions and strategic partnerships. The industry is characterized by the constant need for innovation and the legal complexities surrounding patent enforcement and monetization.

Regulatory Implications

As a company whose revenue is largely derived from intellectual property licensing and litigation, Network-1 Technologies is subject to the evolving legal and regulatory landscape surrounding patent law. Changes in patentability standards, enforcement mechanisms, or international IP agreements could impact the value and enforceability of its patent portfolio.

What Investors Should Do

  1. Monitor patent litigation outcomes and new licensing agreements closely.
  2. Evaluate the sustainability of dividend payments given the declining cash position.
  3. Assess the long-term value and monetization potential of newly acquired patents and existing portfolios.
  4. Analyze the performance and risk associated with the $7 million equity investment in ILiAD Biotechnologies.

Key Dates

  • 2025-09-30: End of Q3 2025 — Reported a net loss of $560,000 on $0 revenue for the quarter, with cash and cash equivalents at $7.7 million.
  • 2024-09-30: End of Q3 2024 — Reported a net loss of $316,000 on $0 revenue for the quarter.
  • 2025-12-31: End of Fiscal Year 2024 — Cash and cash equivalents stood at $13,145,000.

Glossary

M2M/IoT Patent Portfolio
Patents related to Machine-to-Machine/Internet of Things technology, specifically for authenticating and using eSIM in various devices. (Represents a key area of intellectual property for the company's licensing strategy.)
HFT Patent Portfolio
Patents covering high-frequency trading technologies that address speed and latency issues in trading systems. (Another significant patent portfolio the company aims to monetize through licensing.)
eSIM
Embedded Subscriber Identification Module, a digital SIM that allows devices to connect to cellular networks without a physical SIM card. (Central to the M2M/IoT patent portfolio, indicating a focus on modern connectivity technologies.)
Litigation Settlements
Agreements reached to resolve legal disputes, often involving monetary payments. (A primary source of revenue for Network-1 Technologies, Inc., as indicated by the $150,000 YTD revenue.)
Cash Dividends Paid
Payments made by the company to its shareholders from its earnings or reserves. (A significant outflow of cash ($2,296,000 for the nine months) contributing to the decrease in the company's cash position.)

Year-Over-Year Comparison

Compared to the prior year's quarter, Network-1 Technologies saw a significant increase in its net loss for Q3 2025, rising to $560,000 from $316,000, despite zero revenue in both periods. While the year-to-date net loss improved from $1.89 million to $1.39 million, this was driven by a revenue increase from $100,000 to $150,000, primarily from litigation settlements. Operating expenses have decreased year-over-year, but the substantial decline in cash reserves from $13.1 million to $7.7 million, largely due to dividend payments, presents a key concern.

Filing Stats: 4,460 words · 18 min read · ~15 pages · Grade level 19.5 · Accepted 2025-11-06 16:34:01

Key Financial Figures

  • $0.01 — ch registered Common Stock, par value $0.01 per share NTIP NYSE American Indic

Filing Documents

Financial Statements

Financial Statements Condensed Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024 4 Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2025 and 2024 (unaudited) 5 Condensed Consolidated Statements of Changes in Stockholders' Equity for the three and nine months ended September 30, 2025 and 2024 (unaudited) 6 Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (unaudited) 8 Notes to Unaudited Condensed Consolidated Financial Statements 9 Item 2.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 23 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 29 Item 4.

Controls and Procedures

Controls and Procedures 29 PART II. Other Information Item 1.

Legal Proceedings

Legal Proceedings 30 Item 1A.

Risk Factors

Risk Factors 30 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30 Item 3. Defaults Upon Senior Securities 31 Item 5. Other Information 31 Item 6. Exhibits 32

Signatures

Signatures 33 2 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS This Quarterly Report on Form 10-Q contains "forward-looking statements" that involve risks and uncertainties, as well as assumptions that, if they never materialize or prove incorrect, could cause our results to differ materially from those expressed or implied by such forward-looking statements. The statements contained in this Quarterly Report on Form 10-Q that are not purely historical are forward-looking of 1934, as amended. Such forward-looking statements include any expectation of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management for future operations; factors that may affect our operating results; statements related to future performance and other matters that do not relate strictly to historical facts or statements of assumptions underlying any of the foregoing. Forward-looking statements are often identified by the use of words such as, but not limited to, "anticipate," "believe," "can," "continue," "could," "estimate," "expect," "intend," "may," "will," "plan," "project," "seek," "should," "target," "would," and similar expressions or variations intended to identify forward-looking statements. These events to differ materially from future results expressed or implied by such forward-looking statements. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. Factors that could cause or contribute to such dif

BUSINESS

BUSINESS The Company is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns one-hundred fifteen ( 115 ) U.S. patents, fifty-four ( 54 ) of which have expired, and seventeen ( 17 ) international patents related to (i) the M2M/IoT patent portfolio (the "M2M/IoT Patent Portfolio") relating to, among other things, enabling technology for authenticating and using eSIM (embedded Subscriber Identification Module) technology in Internet of Things ("IoT"), Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers, as well as automobiles; (ii) the HFT patent portfolio (the "HFT Patent Portfolio") covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iii) the Cox patent portfolio (the "Cox Patent Portfolio") relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (iv) the smart home patent portfolio (the "Smart Home Patent Portfolio") relating to, among other things, the enabling technology to support the interoperability of smart home IoT devices; (v) the Mirror Worlds patent portfolio (the "Mirror Worlds Patent Portfolio") relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (vi) the remote power patent (the "Remote Power Patent") covering delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras. 9 NOTE A – BASIS OF PRESENTATION AND NATURE OF BUSINESS (continued) The Company's current strategy includes continuing to pursue licensing oppor

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.